精品国产一区二区桃色

ASBMB Annual Meeting

精品国产一区二区桃色 session focuses on proximity-dependent biotinylation

Anne-Claude Gingras
By Anne-Claude Gingras
March 18, 2021

How proteins interact with one another and with other macromolecules, their organization in cells and how these associations are modulated following perturbations long have defined an important branch of the field of functional proteomics. In the past 10 years, approaches that enable the study of these connections in the context of live cells — and now live organisms — have revolutionized the role of proteomics in cell biology.

This session at the 2021 ASBMB Annual Meeting focuses on proximity-dependent labeling approaches, which allow for the covalent tagging of proteins that have come in close proximity to a bait protein (a protein of interest fused to an enzyme) in the context of living cells. Coupling of this strategy to mass spectrometric identification of the labeled proteins permits the characterization of cellular organization.

Since its first implementation to identify the components of the nuclear lamina in cultured cells, proximity-dependent biotinylation has contributed to better understanding of the composition of both membrane-bound and membraneless organelles, defined new signaling complex components, and illuminated the molecular mechanisms underlying several diseases. Proximity-dependent biotinylation methods, including APEX and BioID, still are developing, permitting new experimental modalities and answering increasingly complex questions.

The three presenters selected by the editorial leadership of Molecular & Cellular Proteomics are early-career researchers pushing the boundaries of proximity-dependent biotinylation methods and their applications.

Tess C. Branon, a postdoctoral fellow at the University of California, Berkeley, will present her work on the directed evolution of promiscuous biotin ligases for efficient proteomic mapping in vivo.

Geoffrey Hesketh, a postdoctoral fellow at the Lunenfeld–Tanenbaum Research Institute of Mount Sinai Hospital in Toronto, will describe how he used proximity-dependent sensors to reveal new intricacies in amino acid signaling.

Ilia Droujinine, a principal investigator and Scripps fellow at Scripps Research in California, will introduce new work exploring protein trafficking by in vivo tissue-specific labeling in Drosophila.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Anne-Claude Gingras
Anne-Claude Gingras

Anne-Claude Gingras is an investigator at the Lunenfeld–Tanenbaum Research Institute of Mount Sinai Hospital in Toronto and a deputy editor of the journal Molecular & Cellular Proteomics.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Ralph G. Yount
In Memoriam

In memoriam: Ralph G. Yount

July 28, 2025

He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women鈥檚 health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.